Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes

Molecular Carcinogenesis

Volumn 19, Issue 2, 1997, Pages 83-90

  Medina Martínez, Olga ^a   Vallejo, Verónica ^a   Guido, Miriam C ^a   García Carrancá, Alejandro ^a,b,c  

^a Ciudad Universitaria ^*  (Mexico)

^b Inst Natl de Cancerologia SS   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

AP 1; Cancer; Protein phosphatase; Transcription; Uterine cervix

Indexed keywords

OKADAIC ACID;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ONCOGENE H RAS; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; UTERINE CERVIX CARCINOMA; VIRUS ONCOGENE;

DNA-BINDING PROTEINS; FEMALE; GENES, RAS; GENES, VIRAL; HELA CELLS; HUMANS; OKADAIC ACID; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PHOSPHOPROTEIN PHOSPHATASE; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; PAPILLOMAVIRUS; TRIXIS;

EID: 1842337419     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199707)19:2<83::AID-MC3>3.0.CO;2-M     Document Type: Article

References (46)

1. zur Hausen H, de Villiers E-M. Human papillomaviruses. Annu Rev Microbiol 48:427-447, 1994.
2. Lowy DR, Kirnbauer R, Schiller JT. Genital human papillomavirus infection. Proc Natl Acad Sci USA 91:2436-2440, 1994.
3. Pirisi L, Yasumoto S, Fellery M, Doninger JK, Di Paolo JA. Transformation of human fibroblast and keratinocytes with human papillomavirus type 16 DNA. J Virol 61:1061-1066, 1987.
4. Bedell MA, Jones KH, Grossmann SR, Laimins LA. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J Virol 63:1247-1255, 1989.
5. Matlashewski G, Schnider J, Banks L, Jones N, Murray A, Crawford L. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J 6:1741-1746, 1987.
6. Crook T, Storey A, Almond N, Osborn K, Crawford L. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc Natl Acad Sci USA 85:8820-8824, 1988.
7. Dyson N, Howley PM, Münger K, Harlow E. The human papillomavirus type 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-936, 1989.
8. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136, 1990.
9. García-Carrancá A, Thierry F, Yaniv M. Interplay of viral and cellular proteins along the long control region of human papillomavirus 18. J Virol 63:4321-4330, 1988.
10. Gloss B, Gloss MY, Meisterernst M, Rogge L, Winnacker EL, Bernard HU. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res 9:3519-3533, 1989.
11. Mack DH, Laimins LA. A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc Natl Acad Sci USA 88:9102-9106, 1991.
12. Hoppe-Seyler F, Butz K, zur Hausen H. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J Virol 65:5613-5618, 1991
13. Hoppe-Seyler F, Butz K. Activation of human papillomavirus 18 E6-E7 oncogene expression by transcription factor Sp-1. Nucleic Acids Res 20:6701-6706, 1992.
14. Thierry F, Spyrou G, Yaniv M, Howley PM. Two AP-1 sites binding jun B are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol 66:3740-3748, 1992.
15. Bos JL. ras oncogenes in human cancer. Cancer Res 49:4682-4689, 1989.
16. Barbacid M. ras genes. Annu Rev Biochem 56:779-827, 1987.
17. Kyriakis JM, Banergee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-jun kinases. Nature 369:156-160, 1994.
18. Binétruy B, Smeal T, Karin M. Ha-ras augments c-jun activity and stimulates phosphorylation of its activation domain. Nature 351:122-127, 1991.
19. Schöntal A, Alberts AS, Frost JA, Feramisco JR. Differential regulation of jun family gene expression by the tumor promoter okadaic acid. New Biologist 3:977-986, 1991.
20. Alexander DR. The role of phosphatases in signal transduction. New Biologist 2:1049-1062, 1990.
21. Hunter T. Protein kinases and phosphatases: The ying and yang of protein phosphorylation and signaling. Cell 80:225-236, 1995.
22. Tabin CJ, Bradley SM, Bargmann CI, et al. Mechanism of activation of a human oncogene. Nature 300:143-149, 1982.
23. Hirai SI, Bourachot B, Yaniv M. Both Jun and Fos contribute to transcription activation by the heterodimer. Oncogene 5:39-46, 1990.
24. Piette J, Hirai S, Yaniv M. Constitutive synthesis of activator protein 1 transcription factor after viral transformation of mouse fibroblast. Proc Natl Acad Sci USA 85:3401-3405, 1988.
25. Miranda El, Santana C, Rojas E, Hernández S, Ostrosky-Wegman P, García-Carrancá A. Induced mitotic death of HeLa cells by abnormal expression of c-H-ras. Mutat Res 349:173-182, 1996.
26. Wigler MS, Silverstein S, Lee LS, Pellicer A, Cheng Y, Axel R. Transfer of purified herpes simplex thymidine kinase genes to cultured mouse. Cell 11:223-232, 1977.
27. Seed B, Sheen JY. A simple phase-extraction assay for chloramphenicol acetyltransferase activity. Gene 67:271-277, 1988.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254, 1976.
29. Hirai S-l, Ryseck R-P, Mechta F, Bravo R, Yaniv M. Characterization of junD: A new member of the jun proto-oncogene family. EMBO J 8:1433-1439, 1989.
30. Smits PHM, de Ronde A, Smits HL, Minnaar RP, van der Noorda J, ter Schegget J. The 55 KDa regulatory subunit of protein phosphatase 2A plays a role in the activation of the HPV-16 long control region in human cells with a deletion in the short arm of chromosome 11. EMBO J 11:4601-4606, 1992.
31. Wasylyk C, Imler JL, Wasylyk B. Transforming but not immortalizing oncogenes activate the transcription factor PEA-1. EMBO J 7:2475-2483, 1988.
32. Schwarz E, Fresse UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114, 1985.
33. Di Paolo JA, Woodworth CD, Popescu NC, Notario V, Doninger J. Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey-ras Oncogene 4:395-399, 1989.
34. Pecoraro G, Lee M, Morgan D, Defendi U. Evolution of in vitro transformation and tumorigenesis of HPV-16 and HPV-18 immortalized primary cervical epithelial cells. Am J Pathol 138:1-8, 1991.
35. zur Hausen H. Intracellular surveillance of persisting viral infections. Lancet 2:489-491, 1986.
36. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483-16486, 1995.
37. Wilkinson DG, Bhatt S, Rysek RP, Bravo R. Tissue-specific expression of c-jun and junB during organogenesis in the mouse. Development 106:465-471, 1989.
38. Smits PHM, Smits HL, Jebbink MF, ter Shegget J. The short arm of chromosome 11 likely is involved in the regulation of the human papillomavirus type 16 early enhancer-promoter and in the suppression of the transforming activity of the viral DNA. Virology 176:158-165, 1990.
39. Rösl F, Dürst M, zur Hausen H. Selective suppression of human papillomavirus transcription in non tumorigenic cell by 5-azacytidine. EMBO J 7:1321-1327, 1988.
40. Schwarz E, Schneider-Gadike A, zur Hausen H. Human papillomavirus type 18 transcription in cervical carcinoma cell lines and in human cell hybrids. Cancer Cells 5:47-53, 1987.
41. Antinore MJ, Birrer MJ, Patel D, Nader L, McCance DJ. The human papillomavirus type 16 E7 gene product interacts with and tons-activates the AP1 family of transcription factors. EMBO J 15:1950-1969, 1996.
42. Jehn B, Costello E, Marti A, et al. Overexpression of Mos, Ras, Src, and Fos inhibits mouse mammary epithelial cell differentiation. Mol Cell Biol 12:3890-3902, 1992.
43. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 186:131-156, 1994.
44. Wong YF, Chung TK, Cheung TH, Lam SK, Xu YG, Chang AM. Frequent ras gene mutations in squamous cell cervical cancer. Cancer Lett 95:29-32, 1995.
45. Tenti P, Romagnoli S, Silini E, et al. Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix. Int J Cancer 64:9-13, 1995.
46. Lee JH, Lee SK, Yang MH, Ahmed MM, Mohiuddin M, Lee EY. Expression and mutation of H-ras in uterine cervical cancer. Gynecol Oncol 62:49-54, 1996.